Overactive Bladder - Results from #90

Efficacy of transcutaneous electrical nerve stimulation combined with mirabegron therapy compared with mirabegron monotherapy for overactive bladder: a prospective randomized controlled study. June 9, 2024

The association between overactive bladder and systemic immunity-inflammation index: a cross-sectional study of NHANES 2005 to 2018. June 2, 2024

Microbiologist in the Clinic: Postmenopausal Woman with Chronic OAB and Positive Urine Culture. May 31, 2024

New TENSI+ Device for Transcutaneous Posterior Tibial Nerve Stimulation: A Prospective, Multicentre, Post-market Clinical Study. May 31, 2024

Outcomes of para-sacral transcutaneous electric nerve stimulation in treatment of primary and refractory overactive bladder among children. May 19, 2024

The impact of pharmacotherapy on sexual function in female patients being treated for idiopathic overactive bladder: a systematic review. May 19, 2024

Nerve Growth Factor and Brain-Derived Neurotrophic Factor as Potential Biomarkers of Mirabegron Efficacy in Patients with Overactive Bladder Syndrome. May 19, 2024

Tibial Nerve Stimulation for Urge Urinary Incontinence and Overactive Bladder: Narrative Review of Randomized Controlled Trials and Applicability to Implantable Devices. May 17, 2024

Effect of Electroacupuncture Combined with Pelvic Floor Muscle Exercise on Urinary Symptoms, Sexual Dysfunction and Pelvic Floor Muscle Strength in Female Patients with Overactive Bladder: A Retrospective Study. May 12, 2024

Structural Changes in Brain White Matter Tracts Associated with Overactive Bladder Revealed by Diffusion Tensor MRI: Findings from a LURN Cross-Sectional Case-Control Study. May 12, 2024

Does the setting for intradetrusor onabotulinumtoxinA injection for management of overactive bladder matter? May 12, 2024

Outcomes of sequential third-line therapies in patients with refractory overactive bladder. May 5, 2024

Anticholinergic Burden in Patients Treated for Overactive Bladder: Second-Line Therapy with Tibial Nerve Stimulation as a Solution. May 5, 2024

Intravesical Injection of OnabotulinumtoxinA (Botulinum Toxin Type A) in Japanese Patients With Refractory Overactive Bladder. May 5, 2024

Efficacy and safety of pelvic floor magnetic stimulation combined with mirabegron in female patients with refractory overactive bladder: a prospective study. April 28, 2024

Efficacy and safety of solifenacin combined with biofeedback in children with overactive bladder. April 28, 2024

The AUA/SUFU Guideline on the Diagnosis and Treatment of Idiopathic Overactive Bladder. April 25, 2024

Examining the safety of mirabegron: an analysis of real-world pharmacovigilance data from the US FDA adverse event reporting system (FAERS) database. April 23, 2024

Percutaneous tibial nerve stimulation for the overactive bladder: A single-arm trial. April 21, 2024

Percutaneous tibial neuromodulation initial therapy compliance and subsequent third-line treatment patterns. April 21, 2024

Page 5 of 122